Outwitting multidrug resistance to antifungals

Monk, Brian C.;Goffeau, André
(2008) Science (New York, N.Y.) — Vol. 321, n° 5887, p. 367-369 (2008)

Files

document.pdf
  • Restricted Access
  • Adobe PDF
  • 520.43 KB
Request a copy

Details

Authors
  • Monk, Brian C.
    Author
  • Goffeau, AndréUCLouvain
    Author
Abstract
The economic cost of fungal infection and its mortality associated with multidrug resistance remain unacceptably high. Recent understanding of the transcriptional regulation of plasma membrane efflux pumps of modest specificity provides new avenues for the development of broad-spectrum fungicides. Together with improved diagnosis and indirect intervention via inhibition of the energy supply for drug efflux, we envisage multifunctional azole analogs that inhibit not only ergosterol biosynthesis and drug efflux-pump activity but also activation of the transcriptional machinery that induces drug efflux-pump expression.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Monk, B. C., & Goffeau, A. (2008). Outwitting multidrug resistance to antifungals. Science (New York, N.Y.), 321(5887), 367-369. https://doi.org/10.1126/science.1159746 (Original work published 2008)